Ads
related to: paroxetine 20mg patient information- Full Prescribing Info
Please See Full Prescribing Info
For REXULTI® (brexpiprazole).
- Taking REXULTI®
Find Information About Taking
REXULTI® (brexpiprazole).
- REXULTI® Symptom Tracker
Share The Results With Your Doctor
& See If REXULTI® Is Right For You
- REXULTI® FAQs
Get Answers to Questions
About REXULTI® (brexpiprazole).
- REXULTI® Savings Card
$0 for Your First Prescription
Conditions Apply. Learn More.
- Watch Helpful Videos
Watch Our Video Series On A
Patient's Journey To REXULTI®
- Full Prescribing Info
Search results
Results From The WOW.Com Content Network
Paroxetine, sold under the brand name Paxil among others, is an antidepressant medication of the selective serotonin reuptake inhibitor (SSRI) class [7] used to treat major depressive disorder, obsessive–compulsive disorder (OCD), panic disorder, social anxiety disorder, post-traumatic stress disorder (PTSD), generalized anxiety disorder, and premenstrual dysphoric disorder. [7]
Hypomania, [7] [unreliable medical source] [8] [9] [unreliable medical source] may occur in as many as 8% of patients being treated with paroxetine. May be more common in those with bipolar disorder. Asthenia; Weight gain or loss. Usually gain, paroxetine tends to produce more weight gain than other SSRIs. [6]: 58 Confusion; Emotional lability ...
This is a list of psychiatric medications used by psychiatrists and other physicians to treat mental illness or distress.. The list is ordered alphabetically according to the condition or conditions, then by the generic name of each medication.
Online, people claim they get brain zaps after stopping use of drugs like Lexapro (escitalopram), Cymbalta (duloxetine), and Paxil (paroxetine), but they can happen when you stop taking any type ...
Paroxetine (Paxil, Pexeva) ... 10mg and 20mg tablets. For depression, escitalopram is normally prescribed at a dosage of 10mg to 20mg, taken one time per day. ... It can also help patients deal ...
Over two million prescriptions for paroxetine were written for children or adolescents in the US in 2002. [29]Funded by SmithKline Beecham, the acute phase of study 329 was an eight-week, double-blind, randomized clinical trial conducted in 12 university or hospital psychiatric departments in the United States and Canada between 1994 and 1997.